Maribel Díaz-Ricart
Research group
- Hemotherapy - hemostasis Group leader (R4)
Featured publications
-
Progressive endothelial cell damage in correlation with sepsis severity
Authors:Reference: Journal Of Thrombosis And Haemostasis 2021. -
Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia
Authors:Reference: Cardiovascular Drugs And Therapy 2021. -
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy
Authors:Reference: British Journal Of Haematology 2021. -
Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics
Authors:Reference: Scientific Reports 2021. -
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium
Authors:Reference: Bone Marrow Transplantation 2020. -
Endothelial damage, inflammation and immunity in chronic kidney disease
Authors:Reference: Toxins 2020. -
Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
Authors:Reference: Journal Of Cellular And Molecular Medicine 2020. -
Complement Activation and Thrombotic Microangiopathies.
Authors:Reference: Clinical Journal Of The American Society Of Nephrology 2019. -
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
Authors:Reference: Frontiers In Immunology 2019. -
Endothelial damage is aggravated in acute GvHD and could predict its development.
Authors:Reference: Bone Marrow Transplantation 2017.
Featured Projects
-
Protection of the endothelium during steroid-refractory GVHD. 03R/2019. CoIP w
Principal investigator: ENRIQUE CARRERAS PONSFunder: Instituto de Investigación contra la leucemia Josep Carreras (Sede o evento)Duration: 01/11/2019 - 31/10/2021 -
Grupo de Fisiología, Hemostasia y Trombosis. 2017-SGR671. Investigador Asociado
Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Duration: 01/01/2018 - 31/12/2020 -
Microchips para la evaluación global de la hemostasia en la cabecera del paciente (POC): Aplicaciones en la detección de alteraciones y en el seguimiento de las terapias antitrombóticas. DTS16/00133. Investigador Asociado.
Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Duration: 01/01/2017 - 31/12/2018 -
Enhancement of endothelial regeneration and endothelial funcion during graft versus host disease. 11R/2016. CoIP w
Principal investigator: ENRIQUE CARRERAS PONSFunder: Instituto de Investigación contra la leucemia Josep Carreras (Sede o evento)Duration: 01/11/2016 - 31/10/2019 -
Effects of apixaban beyond anticoagulation: potential protective role on endothelial dysfunction. ERISTA15. IP.
Principal investigator: M.ISABEL DIAZ RICARTFunder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Duration: 01/01/2016 - 31/12/2017